Evidence map›Paper›PMID 41275174›Full record

ArticleBMC public health2025

Exploring differences in HIV stigma and treatment interruptions between young and older adults in Zimbabwe.

Venessa Chen, Gnilane Turpin, Omar Syarif, Pim Looze, Amrita Rao, Carrie Lyons, Hector Moran, Katarzyna Lalak, Jean de Dieu Anoubissi, Fletcher Chiu and 9 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Venessa ChenJohns Hopkins Bloomberg School of Public Health, Baltimore, United States. vchen28@jh.edu.
Gnilane TurpinJohns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Omar SyarifGlobal Network of People Living with HIV, Amsterdam, The Netherlands.
Pim LoozeGlobal Network of People Living with HIV, Amsterdam, The Netherlands.
Amrita RaoJohns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Carrie LyonsJohns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Hector MoranJohns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Katarzyna LalakGlobal Network of People Living with HIV, Amsterdam, The Netherlands.
Jean de Dieu AnoubissiGlobal Network of People Living with HIV, Amsterdam, The Netherlands.
Fletcher ChiuGlobal Network of People Living with HIV, Amsterdam, The Netherlands.
Sophie BrionThe International Community of Women Living with HIV, Nairobi, Kenya.
Keren DunawayThe International Community of Women Living with HIV, Nairobi, Kenya.
Laurel SpragueUNAIDS, Geneva, Switzerland.
Carlos Garcia de Leon MorenoUNAIDS, Geneva, Switzerland.
Daria OcheretUNAIDS, Geneva, Switzerland.
Tatenda MakoniZimbabwe National Network of People Living with HIV/AIDS, Harare, Zimbabwe.
Tonderai MwarekaZimbabwe National Network of People Living with HIV/AIDS, Harare, Zimbabwe.
Stefan BaralJohns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Katherine RucinskiJohns Hopkins Bloomberg School of Public Health, Baltimore, United States.

Funding

Integrating the Visualization and Use of Stigma Data to Maximize the Impact of the Ending the HIV Epidemic InitiativeR01MH132150 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Stefan David Baral · 2022 to 2026
$5.1M
Leveraging Big Data Science to Focus the HIV Response in Countries with Generalized HIV EpidemicsR01AI170249 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BARAL, STEFAN DAVID · 2022 to 2025
$2.9M
Implementation Research to Optimize ART Delivery for Adolescents and Young Adults Living with HIVK01MH129226 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Katherine B Rucinski · 2022 to 2026
$792k
Program and implementation context of a housing support initiative to address homelessness and improve HIV service uptake among youth in the United StatesK01MD020002 · NIMHD · JOHNS HOPKINS UNIVERSITY · PI Amrita Rao · 2024 to 2026
$381k
National Institute of Allergy and Infectious Diseases R01AI170249NIAID NIH HHS R01 AI170249NIMHD NIH HHS K01 MD020002NIMH NIH HHS K01 MH129226NIMH NIH HHS K01MH129226NIMH NIH HHS R01 MH132150NIMH NIH HHS R01MH132150
6 · The paper itself

Abstract

introductionHIV stigma negatively impacts antiretroviral therapy (ART) adherence in adults, but this relationship remains underexplored within the context of early adulthood. We examined manifestations of stigma and their associations with ART interruptions among young (18-24 years) and older (25 + years) people living with HIV (PLHIV) in Zimbabwe.

methodsThis analysis utilized cross-sectional data from the 2021 PLHIV Stigma Index 2.0, implemented by the Zimbabwe National Network of PLHIV in partnership with Global Network of People Living with HIV, The International Community of Women Living with HIV, and UNAIDS. Treatment interruptions were defined as ever interrupting or stopping HIV treatment. Internalized, anticipated, and enacted stigma scores were categorized as "no", "low", "moderate" and "high". Modified Poisson regression models estimated associations between categorized stigma scores and treatment interruptions, with age-stratified analyses among young and older adults.

resultsAmong 1347 PLHIV who ever initiated ART, 20.9% of young adults and 10.3% of older adults reported treatment interruptions. Experiences of internalized stigma (56.3% versus 41.7%, p < 0.01) and anticipated stigma (73.9% versus 51.8%, p < 0.01) were higher among young adults compared to older adults. Increasing levels of internalized stigma were associated with higher lifetime incidence of treatment interruptions compared to no stigma (low: adjusted risk ratio(aRR)1.67, 95%CI 1.08-2.58, moderate: aRR2.58, 95%CI 1.72-3.87, high: aRR3.54, 95%CI 2.11-5.94). Similar associations were observed with anticipated stigma (low: aRR2.24, 95%CI 1.49-3.36, moderate: aRR3.21, 95%CI 1.82-5.66, high: aRR4.88, 95%CI 2.75-8.67). Treatment interruptions were associated with high (versus no) enacted stigma (aRR 2.75, 95%CI 1.19-6.32).

conclusionYoung adults living with HIV in Zimbabwe reported twice the lifetime incidence of treatment interruptions and greater levels of internalized and anticipated stigma compared to older adults. The associations between stigma and treatment interruptions highlight the opportunity for interventions that address stigma for young adults, which may optimize treatment adherence during early adulthood.

Indexed as

Anti-HIV AgentsHIV InfectionsMedication AdherenceSocial StigmaAdolescentAdultAgedAge FactorsCross-Sectional StudiesFemaleHumansMaleMiddle AgedYoung AdultZimbabweAnti-HIV AgentsHIVHIV stigmaHIV treatmentTreatment interruptionYoung adultZimbabwe

Identifiers

PMID41275174
PMCPMC12754962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.